Read More Pharma Industry News Niktimvo FDA approval brings new hope for chronic graft-versus-host disease patients The U.S. Food and Drug Administration (FDA) has approved Niktimvo (axatilimab-csfr), an anti-CSF-1R antibody, for treating chronic graft-versus-host… byPallavi MadhirajuAugust 15, 2024